Small pituitary volume and central nervous system anomalies in Fanconi Anemia.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2024
Historique:
received: 10 05 2024
accepted: 30 07 2024
medline: 3 9 2024
pubmed: 3 9 2024
entrez: 3 9 2024
Statut: epublish

Résumé

Fanconi anemia (FA) is a genomic instability disorder associated with congenital abnormalities, including short stature and the presence of central nervous system anomalies, especially in the hypothalamic-pituitary area. Thus, differences in pituitary size could associate with the short stature observed in these patients. Our aim was to evaluate whether central nervous system abnormalities and pituitary gland volume correlate with height and hormone deficiencies in these patients. In this cross-sectional exploratory study 21 patients diagnosed with FA between 2017 and 2022 in a Spanish Reference Center were investigated. Magnetic resonance imaging (MRI) was performed and pituitary volume calculated and corelated with height and other endocrine parameters. The percentage of abnormalities in our series was 81%, with a small pituitary (pituitary volume less than 1 SD) being the most frequent, followed by Chiari malformation type 1. The median value of pituitary volume was -1.03 SD ( Central nervous system anomalies are part of the FA phenotype, the most frequent after pituitary hypoplasia being posterior fossa abnormalities, which may have clinical repercussions in the patient. It is therefore necessary to identify those who could be candidates for neurosurgical intervention. The size of the pituitary gland is smaller in these patients, but this does not seem to be related to hormone deficiency and short stature or exposure to a low dose of total body irradiation.

Identifiants

pubmed: 39224124
doi: 10.3389/fendo.2024.1385650
pmc: PMC11366589
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1385650

Informations de copyright

Copyright © 2024 Corredor, Solís, Zubicaray, Sevilla and Argente.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Beatriz Corredor (B)

Department of Pediatrics, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Department of Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Department of Pediatrics, Hospital Universitario de Toledo, Toledo, Spain.
Department of Pediatric Endocrinology, Hospital Universitario de Toledo, Toledo, Spain.

Inés Solís (I)

Department of Pediatric Radiology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

Josune Zubicaray (J)

Department of Pediatric Hematology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Fundación de Investigación del Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Center for Biomedical Research on Rare Diseases Network (CIBERER), Madrid, Spain.

Julián Sevilla (J)

Department of Pediatric Hematology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Fundación de Investigación del Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Center for Biomedical Research on Rare Diseases Network (CIBERER), Madrid, Spain.

Jesús Argente (J)

Department of Pediatrics, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Department of Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Department of Pediatric Endocrinology, La Princesa Research Institute, Madrid, Spain.
Department of Pediatrics, Universidad Autónoma de Madrid, Madrid, Spain.
Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutriciόn (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
IMDEA, Food Institute, CEIUAM+CSI, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH